Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin R tenOever

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Cell Metabolism|October 2, 2021
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
NPJ Genomic Medicine|September 5, 2022
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibilityGeorgios Voloudakis, James M Vicari, Sanan Venkatesh, et al.
Nature|May 29, 2024
Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoidsYuling Han, Xiaohua Duan, Liuliu Yang, et al.
Nature|October 29, 2020
Identification of SARS-CoV-2 inhibitors using lung and colonic organoidsYuling Han, Xiaohua Duan, Liuliu Yang, et al.
Cell Stem Cell|June 25, 2020
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and OrganoidsLiuliu Yang, Yuling Han, Benjamin E Nilsson-Payant, et al.
Cell Stem Cell|October 7, 2022
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variantsYuling Han, Lei Tan, Ting Zhou, et al.
Nature Biomedical Engineering|May 4, 2021
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylacticsLonglong Si, Haiqing Bai, Melissa Rodas, et al.
Biorxiv : the Preprint Server for Biology|March 2, 2022
TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTIONJoseph W Guarnieri, Joseph M Dybas, Hossein Fazelinia, et al.
Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cell Metabolism|October 2, 2021
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
NPJ Genomic Medicine|September 5, 2022
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibilityGeorgios Voloudakis, James M Vicari, Sanan Venkatesh, et al.
Nature|May 29, 2024
Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoidsYuling Han, Xiaohua Duan, Liuliu Yang, et al.
Nature|October 29, 2020
Identification of SARS-CoV-2 inhibitors using lung and colonic organoidsYuling Han, Xiaohua Duan, Liuliu Yang, et al.
Cell Stem Cell|June 25, 2020
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and OrganoidsLiuliu Yang, Yuling Han, Benjamin E Nilsson-Payant, et al.
Cell Stem Cell|October 7, 2022
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variantsYuling Han, Lei Tan, Ting Zhou, et al.
Nature Biomedical Engineering|May 4, 2021
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylacticsLonglong Si, Haiqing Bai, Melissa Rodas, et al.
Biorxiv : the Preprint Server for Biology|March 2, 2022
TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTIONJoseph W Guarnieri, Joseph M Dybas, Hossein Fazelinia, et al.
Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Pageof 13